Studies have shown that medication non-adherence is related to greater morbidity and mortality in chronic disease, including coronary heart disease patients (1). In addition, patients who experience impaired quality of life (QOL) have reported low medication adherence. The purpose of the present study was to evaluate relationship between QOL and patient symptoms and compliance. This is a retrospective cohort study of 196 patients who underwent coronary artery bypass grafting (CABG) 5 years prior. Medication and follow-up visit adherence, post-CABG symptoms and events, and QOL were assessed using study checklist and 36-item health related QOL questionnaire. Fiveyear survival rate of discharged patients was 87% (SE: 0.032). Kaplan-Meier survival curves did not show difference between men and women (men: 89%, women: 82%; p=0.3). Frequency of rehospitalization for cardiac reasons, re-angiogram, and percutaneous coronary intervention in CABG cohort during 5-year period was 18.8%, 7.3%, and 3.1%, respectively. Medication and follow-up visit non-adherence rates were 10
Medication adherence and quality of life in coronary artery bypass grafting patients, results of retrospective cohort study gery due to angina relief. Other factors that may make patient QOL worse are adverse effects of medications and cost (5) . It is important that perceived health-related personal control and self-efficacy be considered in interpretation of patient adherence studies. Result of present study indicates state of patient adherence and symptoms 5 years after surgery may be different from early months. Association of adherence to various medications like aspirin, statin, beta-blocker, etc. with patient symptoms and cardiac event need to be studied in other research. Also, assessment of patient adherence and QOL at different intervals following CABG and with socio -economic state of population taken into account are proposed. 
